(IBDT) iShares iBonds Dec 2028 - Ratings and Ratios
Investment-Grade Bonds, Corporate Debt, Maturity 2028, U.S. Dollar
Dividends
| Dividend Yield | 4.53% |
| Yield on Cost 5y | 4.73% |
| Yield CAGR 5y | 8.91% |
| Payout Consistency | 95.6% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 1.47% |
| Value at Risk 5%th | 2.37% |
| Relative Tail Risk | -2.24% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.87 |
| Alpha | 1.98 |
| CAGR/Max DD | 1.35 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.384 |
| Beta | 0.025 |
| Beta Downside | 0.001 |
| Drawdowns 3y | |
|---|---|
| Max DD | 4.19% |
| Mean DD | 0.88% |
| Median DD | 0.55% |
Description: IBDT iShares iBonds Dec 2028 November 09, 2025
The iShares iBonds Dec 2028 Term Corporate ETF (IBDT) commits at least 80% of its assets to the securities that compose its underlying index and at least 90% to fixed-income instruments of the same types, focusing on U.S. dollar-denominated, investment-grade corporate bonds with a minimum $300 million face value, issued by both U.S. and non-U.S. companies.
Key metrics to watch include its weighted-average maturity of roughly 8 years, an expense ratio near 0.15%, and a current yield-to-maturity of about 4.2%, which reflects the prevailing term premium and corporate credit spreads. The fund’s performance is especially sensitive to Federal Reserve policy cycles: a tightening environment tends to compress spreads and push yields higher, while a dovish stance can boost bond prices. Additionally, the concentration in higher-rated (A-BBB) issuers means the ETF’s credit risk is closely tied to macro-economic health in the industrial and technology sectors, which dominate the index composition.
For a deeper, data-driven assessment of IBDT’s risk-adjusted return profile, you might explore the analytics platform ValueRay, which offers granular scenario modeling and peer comparisons.
What is the price of IBDT shares?
Over the past week, the price has changed by +0.18%, over one month by +0.28%, over three months by +1.31% and over the past year by +6.08%.
Is IBDT a buy, sell or hold?
What are the forecasts/targets for the IBDT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 27.4 | 7.2% |
IBDT Fundamental Data Overview November 21, 2025
Beta = 0.73
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.26b USD (3.26b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 3.26b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 3.26b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.11% (E(3.26b)/V(3.26b) * Re(6.11%) + (debt-free company))
Discount Rate = 6.11% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBDT ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle